Frequency Maternal and Neonatal Outcomes in Pregnant Women with Gestational Diabetes Mellitus Treated with Metformin in Ahvaz in 2018-2019

Document Type : Original Article

Authors

1 Associate Professor of Endocrinology, Diabetes Research Center, Health Research Institute, Ahvaz Jundishapur of Medical Sciences, Ahvaz, Iran.

2 Internal medicine residency student, Diabetes Research Center, Health Research Institute, Ahvaz Jundishapur of Medical Sciences, Ahvaz, Iran.

10.61186/jsmj.2022.350714.2882

Abstract

Background and Objectives Metformin is increasingly used as an effective treatment for gestational diabetes (GDM). However, the impact of metformin treatment on maternal and neonatal outcomes is not well known. The aim of this study was to evaluate the frequency of maternal and fetal outcomes in women with gestational diabetes treated with metformin in Ahvaz. Subjects and Methods This retrospective study was conducted on 314 women with gestational diabetes treated with metformin in the outpatient department of Imam Khomeini Hospital in Ahvaz during 1397-98. The women were followed up until delivery and maternal and neonatal outcomes were assessed. Results The result of this study showed that 32 patients (10.2%) had preterm labor, 2 patients (0.6%) had preeclampsia 6 patients (1.9%), had low birth weight (LBW), 1 patient (0.3%) had macrosomia, and 6 patients (1.9%) had neonatal hypoglycemia. Abnormal blood glucose 6 weeks after delivery was observed in 13 cases (4.1%). In all but 8 (2.5%) women with GDM, optimal glycemic control (HbA1C<6.5) was achieved with metformin alone. There was no significant association between maternal and neonatal outcomes and baseline characteristics of metformin-treated women with GDM. Conclusion Our study shows that metformin is effective and safe in the treatment of GDM. It is not associated with an increased risk of adverse maternal-fetal complications and can be used as a useful treatment in the management of gestational diabetes to reduce the costs associated with gestational diabetes.

Keywords

Main Subjects

References

[1] Buchanan TA, Xiang AH. Gestational diabetes mellitus. The Journal of clinical investigation. 2005;115(3):485-91. [DOI:10.1172/JCI24531] [PMID] [PMCID]
[2] Nguyen CL, Pham NM, Binns CW, Duong DV, Lee AH. Prevalence of Gestational Diabetes Mellitus in Eastern and Southeastern Asia: A Systematic Review and Meta-Analysis. J Diabetes Res. 2018;2018:6536974. [DOI:10.1155/2018/6536974] [PMID] [PMCID]
[3] Kheir AEM, Berair R, Gulfan IGI, Karrar MZ, Mohammed ZAO. Morbidity and mortality amongst infants of diabetic mothers admitted into Soba university hospital, Khartoum, Sudan. Sudan J Paediatr. 2012;12(1):49-55. [PMID] [PMCID]
[4] Rosenn B, Miodovnik M, Combs CA, Khoury J, Siddiqi TA. Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstetrics and gynecology. 1994;84(4):515-20. [PMID]
[5] Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients. Biomark Insights. 2016;11:95-104. [DOI:10.4137/ BMI.S38440] [PMID] [PMCID]
[6] Asif M. The prevention and control the type-2 diabetes by changing lifestyle and dietary pattern. J Educ Health Promot. 2014;3:1. [DOI:10.4103/2277-9531.127541] [PMID]
[7] Alfadhli EM. Gestational diabetes mellitus. Saudi Med J. 2015;36(4):399-406. [DOI:10.15537/smj. 2015.4.10307] [PMID] [PMCID]
[8] Arshad R, Karim N, Ara Hasan J. Effects of insulin on placental, fetal and maternal outcomes in gestational diabetes mellitus. Pak J Med Sci. 2014;30(2):240-4. [DOI:10.12669/pjms.302.4396] [PMID]
[9] Dumitrescu R, Mehedintu C, Briceag I, Purcărea VL, Hudita D. Metformin-clinical pharmacology in PCOs. J Med Life. 2015;8(2):187-92. [PMID] [PMCID]
[10] Church TJ, Haines ST. Treatment Approach to Patients With Severe Insulin Resistance. Clin Diabetes. 2016;34(2):97-104. [DOI:10.2337/diaclin. 34.2.97] [PMID] [PMCID]
[11] Priya G, Kalra S. Metformin in the management of diabetes during pregnancy and lactation. Drugs Context. 2018;7:212523. [DOI:10.7573/dic.212523] [PMID] [PMCID]
[12] Mousa A, Løvvik T, Hilkka I, Carlsen SM, Morin-Papunen L, Tertti K, et al. Metformin in Pregnancy Study (MiPS): protocol for a systematic review with individual patient data meta-analysis. BMJ Open. 2020;10(5):e036981. [DOI:10.1136/bmjopen-2020-036981] [PMID] [PMCID]
[13] Nasri H, Rafieian-Kopaei M. Metformin: Current knowledge. J Res Med Sci. 2014;19(7):658-64. [PMID]
[14] Committee SoM-FMP. SMFM statement: pharmacological treatment of gestational diabetes. Am J Obstet Gynecol. 2018;218(5):B2-4. [DOI:10. 1016/j.ajog.2018.01.041] [PMID]
[15] Singh AK, Singh R. Metformin in gestational diabetes: An emerging contender. Indian J Endocrinol Metab. 2015;19(2):236-44. [DOI:10. 4103/2230-8210.149317] [PMID]
[16] Reynolds RM, Denison FC, Juszczak E, Bell JL, Penneycard J, Strachan MWJ, et al. Glibenclamide a`nd metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial. BMC Pregnancy Childbirth. 2017;17(1):316. [DOI:10.1186/s12884-017-1505-3] [PMID] [PMCID]
[17] Fulcher G, Glastras S, Hocking S, McGrath R, Scott E. Outcomes for Women with Gestational Diabetes Treated with Metformin: A Retrospective, Case-Control Study. 2018;7(3):50. [DOI:10.3390/jcm7 030050] [PMID] [PMCID]
[18] McGrath RT, Glastras SJ, Hocking S, Fulcher GR. Use of metformin earlier in pregnancy predicts supplemental insulin therapy in women with gestational diabetes. Diabetes research and clinical practice. 2016;116:96-9. [DOI:10.1016/j.diabres. 2016.04.051] [PMID]
[19] Spaulonci CP, Bernardes LS, Trindade TC, Zugaib M, Francisco RPV. Randomized trial of metformin vs insulin in the management of gestational diabetes. American journal of obstetrics and gynecology. 2013;(1):34.e1-7 . [DOI:10.1016/j.ajog.2013.03.0 22] [PMID]
[20] Goh J, Sadler L, Rowan J. Metformin for gestational diabetes in routine clinical practice. Diabetic Medicine. 2011;28(9):1082-7. [DOI:10.1111/j. 1464-5491.2011.03361.x] [PMID]
[21] Simeonova-Krstevska S, Bogoev M, Bogoeva K, Zisovska E, Samardziski I, Velkoska-Nakova V, et al. Maternal and Neonatal Outcomes in Pregnant Women with Gestational Diabetes Mellitus Treated with Diet, Metformin or Insulin. Open Access Maced J Med Sci. 2018;6(5):803-7. [DOI:10.3889/ oamjms.2018.200] [PMD] [PMCID]
[22] Hughes R, Rowan J. Pregnancy in women with Type 2 diabetes: who takes metformin and what is the outcome? Diabetic Medicine. 2006;23(3):318-22. [DOI: 10.1111/j.1464-5491.2006.01750.x] [PMID]
[23] Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes. 2008;57(5):1349-54. [DOI:10.2337/db08-0063] [PMID]
[24] Saleh HS, Abdelsalam WA, Mowafy HE, Abd ElHameid AA. Could metformin manage gestational diabetes mellitus instead of insulin? International journal of.reproductive medicine. 2016;
Jundishapur
Journal of Medical Sciences
May & June 2023. Vol 22. No 1
Rashidi H, et al. Pregnant Women with Gestational Diabetes Mellitus Treated with Metformin. 2023; 22(1):99-109
109
2016:3480629. [DOI:10.1155/2016/3480629] [PMID] [PMCID]
[25] lavanya Rai MD, Kamath A. Metformin-a convenient alternative to insulin for Indian women with diabetes in pregnancy. Indian J Med Sci. 2009;63(11):491-7. [PMID]
[26] Butalia S, Gutierrez L, Lodha A, Aitken E, Zakariasen A, Donovan L. Short-and long-term outcomes of metformin compared with insulin alone in pregnancy: a systematic review and meta-analysis. Diabetic Medicine. 2017;34(1):27-36. [DOI:10. 1111/dme.13150] [PMID]
Jundishapur Scientific Medical Journal
Volume 22, Issue 1 - Serial Number 142
March and April 2023
Pages 99-109

Files

History

  • Receive Date: 07 July 2022
  • Revise Date: 28 August 2022
  • Accept Date: 12 October 2022

Share

How to cite

Statistics